Methotrexate guidelines—revised

Journal of the American Academy of Dermatology

Volumn 6, Issue 2, 1982, Pages 145-155

  Roenigk, Henry H ^a   Auerbach, Robert ^b   Maibach, Howard I ^c   Weinstein, Gerald D ^d  

^a NORTHWESTERN UNIVERSITY   (United States)

^b University of California Medical Center ^*  (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE;

ADVERSE DRUG REACTION; DIAGNOSIS; DRUG INTERACTION; DRUG THERAPY; HISTOLOGY; INTOXICATION; LIVER; LIVER TOXICITY; PSORIASIS; REVIEW; SKIN DISEASE; THERAPY;

EID: 0020472266     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(82)80064-9     Document Type: Article

References (51)

1. Antineoplastic agents and the liver
2. Methotrexate hepatotoxicity in psoriasis—consideration of liver biopsies at regular intervals
3. Liver disease in psoriatics—an effect of methotrexate therapy
4. Methotrexate hepatotoxicity in psoriasis—comparison of different dose regimens
5. Liver biopsies from psoriatics related to methotrexate therapy. 1. Findings in 123 consecutive non-methotrexate treated patients
6. Liver biopsies from psoriatics related to methotrexate therapy. 2. Findings before and after methotrexate therapy in 88 patients. A blind study
7. Liver biopsies from psoriatics related to methotrexate therapy. 3. Findings in post-methotrexate liver biopsies from 160 psoriatics
8. Liver ultrastructure in psoriatics related to methotrexate therapy. 1. A prospective study of findings in hepatocytes from 24 patients before and after MTX treatment
9. Benefits and adverse drug experiences during long-term methotrexate treatments of 248 psoriatics
10. Liver injury associated with methotrexate therapy for psoriasis
11. Effects of methotrexate on the liver in psoriasis
12. Methotrexate for psoriasis in weekly oral doses
13. A cooperative prospective study of the effects of chemotherapy of psoriasis on liver biopsies
14. Hepatotoxicity of long-term methotrexate therapy for psoriasis
15. A prospective study of the effects of weekly oral methotrexate on liver biopsy. Findings in severe psoriasis
16. Psoriasis-liver methotrexate interactions
17. Liver biopsy in methotrexate-treated psoriatics—a re-evaluation
18. Accidental kidney biopsies in psoriasis
19. Methotrexate induced liver cirrhosis
20. Acute and chronic effects of methotrexate on hepatic, pulmonary and skeletal systems
21. Renal function and the rate of disappearance of methotrexate from serum
22. Rapid plasma clearance and reduced rate and extent of urinary elimination of parenterally administered methotrexate as a result of severe vomiting and diarrhea
23. Comparison of serum concentrations of methotrexate after various routes of administration
24. The metabolic fate of tritiated methotrexate. 1. Absorption, excretion, and distribution in mice, rats, dogs, and monkeys
25. The metabolic fate of tritiated methotrexate. II. Absorption and excretion in man
26. Assay of therapeutic doses of methotrexate in body fluids of patients with psoriasis
27. Clinical pharmacokinetics of methotrexate
28. Effect of sodium salicylate and indomethacin on methotrexate serum albumin binding
29. Methotrexate for psoriasis—a new therapeutic schedule
30. Bioavailability of methotrexate: Implications for clinical use
31. Drug interaction in psoriasis
32. Deficient folate activity during treatment of psoriasis with methotrexate diagnosed by determination of serine synthesis in lymphocytes
33. Increased methotrexate toxicity due to concurrent probenecid administration
34. Is methotrexate therapy for psoriasis carcinogenic?: A modified retrospective-prospective analysis
35. Mutagenicity of cancer chemotherapeutic agents in the salmonella/microsome test
36. Studies on human semen in topical corticosteroid-treated and in methotrexate psoriatics
37. Psoriasis, methotrexate and oligospermia
38. Methotrexate and fertility in men
39. Chromosomal investigation in pregnancies following chemotherapy for choriocarcinoma
40. Comparative studies of rubella antibodies in psoriatic patients treated with methotrexate
41. Pulmonary disease complicating intermittent therapy with methotrexate
42. Methotrexate pneumonitis in a psoriatic
43. Methotrexate-induced diffuse interstitial pulmonary fibrosis
44. Systemic corticosteroids and folic acid antagonists in the treatment of generalized pustular psoriasis. Evaluation and prognosis based on the study of 104 cases
45. The clinical pharmacology of methotrexate: New applications of an old drug
46. Chemotherapy of psoriasis, ten years of experience
47. Methotrexate-diagnosis and treatment
48. Guidelines on methotrexate therapy for psoriasis
49. Methotrexate therapy for psoriasis—revision of guidelines
50. Reactivation of acute inflammation by methotrexate